Rajendran JG - Search Results

1

High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.

Rajendran JG, Fisher DR, Gopal AK, Durack LD, Press OW, Eary JF. Rajendran JG, et al. J Nucl Med. 2004 Jun;45(6):1059-64. J Nucl Med. 2004. PMID: 15181141 Free article. Clinical Trial.

2

Comparison of radiation dose estimation for myeloablative radioimmunotherapy for relapsed or recurrent mantle cell lymphoma using (131)I tositumomab to that of other types of non-Hodgkin's lymphoma.

Rajendran J, Gopal A, Durack L, Fisher D, Press O, Eary J. Rajendran J, et al. Cancer Biother Radiopharm. 2004 Dec;19(6):738-45. doi: 10.1089/cbr.2004.19.738. Cancer Biother Radiopharm. 2004. PMID: 15665621

3

90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution.

Matesan M, Rajendran J, Press OW, Maloney DG, Storb RF, Cassaday RD, Pagel JM, Oliveira G, Gopal AK. Matesan M, et al. Nucl Med Commun. 2014 Nov;35(11):1132-42. doi: 10.1097/MNM.0000000000000172. Nucl Med Commun. 2014. PMID: 25076159 Free PMC article.

4

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.

Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW. Gopal AK, et al. Among authors: rajendran jg. Blood. 2002 May 1;99(9):3158-62. doi: 10.1182/blood.v99.9.3158. Blood. 2002. PMID: 11964278 Free article. Clinical Trial.

5

High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation.

Rajendran JG, Eary JF, Bensinger W, Durack LD, Vernon C, Fritzberg A. Rajendran JG, et al. J Nucl Med. 2002 Oct;43(10):1383-90. J Nucl Med. 2002. PMID: 12368378 Free article. Clinical Trial.

6

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

Gopal AK, Gooley TA, Maloney DG, Petersdorf SH, Eary JF, Rajendran JG, Bush SA, Durack LD, Golden J, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW. Gopal AK, et al. Among authors: rajendran jg. Blood. 2003 Oct 1;102(7):2351-7. doi: 10.1182/blood-2003-02-0622. Epub 2003 May 15. Blood. 2003. PMID: 12750161 Free article. Clinical Trial.

7

166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.

Breitz HB, Wendt RE 3rd, Stabin MS, Shen S, Erwin WD, Rajendran JG, Eary JF, Durack L, Delpassand E, Martin W, Meredith RF. Breitz HB, et al. Among authors: rajendran jg. J Nucl Med. 2006 Mar;47(3):534-42. J Nucl Med. 2006. PMID: 16513624 Free article. Clinical Trial.

8

Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.

Gopal AK, Pagel JM, Rajendran JG, Maloney DG, Appelbaum FR, Sorror ML, Sandmaier BM, Storb R, Press OW. Gopal AK, et al. Among authors: rajendran jg. Biol Blood Marrow Transplant. 2006 Jul;12(7):697-702. doi: 10.1016/j.bbmt.2006.03.014. Biol Blood Marrow Transplant. 2006. PMID: 16785058 Free article. Review.

9

High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.

Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW. Gopal AK, et al. Among authors: rajendran jg. J Clin Oncol. 2007 Apr 10;25(11):1396-402. doi: 10.1200/JCO.2006.09.1215. Epub 2007 Feb 20. J Clin Oncol. 2007. PMID: 17312330

10

Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.

Rajendran JG, Gopal AK, Fisher DR, Durack LD, Gooley TA, Press OW. Rajendran JG, et al. J Nucl Med. 2008 May;49(5):837-44. doi: 10.2967/jnumed.107.043190. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413376 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters